Roth Capital Expects Weaker Earnings for Tenax Therapeutics
Tenax Therapeutics, Inc. (NASDAQ:TENX – Free Report) – Roth Capital lowered their FY2027 earnings per share estimates for shares of Tenax Therapeutics in a research report issued on Wednesday, March 5th. Roth Capital analyst J. Aschoff now forecasts that the specialty pharmaceutical company will earn $1.74 per share for the year, down from their prior […]
Tenax Therapeutics, Inc. (NASDAQ:TENX – Free Report) – Roth Capital lowered their FY2027 earnings per share estimates for shares of Tenax Therapeutics in a research report issued on Wednesday, March 5th. Roth Capital analyst J. Aschoff now forecasts that the specialty pharmaceutical company will earn $1.74 per share for the year, down from their prior […]
